- M Dashboard
-
Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Macy's (M) Financial statements
Company Profile
Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | ||
---|---|---|---|---|---|
Total Revenue | |||||
Cost of Revenue | |||||
Gross Profit | |||||
Gross Profit Margin (%) | |||||
R&D Expense | |||||
SG&A Expense | |||||
Total Operating Expenses | |||||
Operating Income or Loss | |||||
Operating Margin (%) | |||||
Interest Expense | |||||
Total Other Income/Expenses | |||||
Income Before Tax | |||||
Income Tax Expense | |||||
Income from Continuing Ops. | |||||
Net Income | |||||
Net Profit Margin (%) | |||||
Net Income Available to Common Shareholders | |||||
Basic EPS | |||||
Diluted EPS | |||||
Basic Average Shares | |||||
Diluted Average Shares |
Nov 2024 | Aug 2024 | May 2024 | Oct 2023 | Jul 2023 | Apr 2023 | Jan 2023 | Oct 2022 | Jul 2022 | Apr 2022 | Jan 2022 | Oct 2021 | Jul 2021 | May 2021 | Jan 2021 | Oct 2020 | Jul 2020 | May 2020 | Jan 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | ||||||||||||||||||||
Cost of Revenue | ||||||||||||||||||||
Gross Profit | ||||||||||||||||||||
Gross Profit Margin (%) | ||||||||||||||||||||
R&D Expense | ||||||||||||||||||||
SG&A Expense | ||||||||||||||||||||
Total Operating Expenses | ||||||||||||||||||||
Operating Income or Loss | ||||||||||||||||||||
Operating Margin (%) | ||||||||||||||||||||
Interest Expense | ||||||||||||||||||||
Total Other Income/Expenses | ||||||||||||||||||||
Income Before Tax | ||||||||||||||||||||
Income Tax Expense | ||||||||||||||||||||
Income from Continuing Ops. | ||||||||||||||||||||
Net Income | ||||||||||||||||||||
Net Profit Margin (%) | ||||||||||||||||||||
Net Income Available to Common Shareholders | ||||||||||||||||||||
Basic EPS | ||||||||||||||||||||
Diluted EPS | ||||||||||||||||||||
Basic Average Shares | ||||||||||||||||||||
Diluted Average Shares |
Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | ||
---|---|---|---|---|---|
Current Assets | |||||
Cash & Cash Equivalents | |||||
Marketable Securities | |||||
Receivables | |||||
Inventories | |||||
Other Current Assets | |||||
Total Current Assets | |||||
Non-Current Assets | |||||
Marketable Securities | |||||
PPE Net | |||||
Intangibles inc. Goodwill | |||||
Other Non-Current Assets | |||||
Total Non-Current Assets | |||||
Total Assets | |||||
Current Liabilities | |||||
Accounts Payable | |||||
Deferred Revenues | |||||
Debt, Current | |||||
Accrued Liabilities | |||||
Other Current Liabilities | |||||
Total Current Liabilities | |||||
Non-Current Liabilities | |||||
Deferred Revenues | |||||
Debt, Non-Current | |||||
Other Non-Current Liabilities | |||||
Total Non-Current Liabilities | |||||
Total Liabilities | |||||
Shareholders' Equity | |||||
Common Stock | |||||
Additional Paid-In Capital | |||||
Retained Earnings | |||||
Other Shareholders' Equity | |||||
Total Shareholders' Equity | |||||
Total Liabilities & Shareholders' Equity |
Nov 2024 | Aug 2024 | May 2024 | Oct 2023 | Jul 2023 | Apr 2023 | Jan 2023 | Oct 2022 | Jul 2022 | Apr 2022 | Jan 2022 | Oct 2021 | Jul 2021 | May 2021 | Jan 2021 | Oct 2020 | Jul 2020 | May 2020 | Jan 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Current Assets | ||||||||||||||||||||
Cash & Cash Equivalents | ||||||||||||||||||||
Marketable Securities | ||||||||||||||||||||
Receivables | ||||||||||||||||||||
Inventories | ||||||||||||||||||||
Other Current Assets | ||||||||||||||||||||
Total Current Assets | ||||||||||||||||||||
Non-Current Assets | ||||||||||||||||||||
Marketable Securities | ||||||||||||||||||||
PPE Net | ||||||||||||||||||||
Intangibles inc. Goodwill | ||||||||||||||||||||
Other Non-Current Assets | ||||||||||||||||||||
Total Non-Current Assets | ||||||||||||||||||||
Total Assets | ||||||||||||||||||||
Current Liabilities | ||||||||||||||||||||
Accounts Payable | ||||||||||||||||||||
Deferred Revenues | ||||||||||||||||||||
Debt, Current | ||||||||||||||||||||
Accrued Liabilities | ||||||||||||||||||||
Other Current Liabilities | ||||||||||||||||||||
Total Current Liabilities | ||||||||||||||||||||
Non-Current Liabilities | ||||||||||||||||||||
Deferred Revenues | ||||||||||||||||||||
Debt, Non-Current | ||||||||||||||||||||
Other Non-Current Liabilities | ||||||||||||||||||||
Total Non-Current Liabilities | ||||||||||||||||||||
Total Liabilities | ||||||||||||||||||||
Shareholders' Equity | ||||||||||||||||||||
Common Stock | ||||||||||||||||||||
Additional Paid-In Capital | ||||||||||||||||||||
Retained Earnings | ||||||||||||||||||||
Other Shareholders' Equity | ||||||||||||||||||||
Total Shareholders' Equity | ||||||||||||||||||||
Total Liabilities & Shareholders' Equity |
Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | ||
---|---|---|---|---|---|
Cash Flows from Operating Activities | |||||
Net Income | |||||
Depreciation & Amortization | |||||
Deferred Income Taxes | |||||
Stock Based Compensation | |||||
Accounts Receivable | |||||
Inventory | |||||
Accounts Payable | |||||
Deferred Revenue | |||||
Other Non-Cash | |||||
Operating Cash Flow | |||||
Cash Flows from Investing Activities | |||||
PPE Investments | |||||
Net Acquisitions | |||||
Purchase of Investments | |||||
Sale of Investments | |||||
Other Investing Activity | |||||
Investing Cash Flow | |||||
Cash Flows from Financing Activities | |||||
Debt Issued | |||||
Proceeds from Debt Repayment | |||||
Debt Repayment | |||||
Proceeds from Sale of Equity | |||||
Equity Repurchased | |||||
Dividend Paid | |||||
Other Financing Activity | |||||
Financing Cash Flow | |||||
Cash Position | |||||
Beginning Cash Position | |||||
End Cash Position | |||||
Change in Cash | |||||
Free Cash Flow | |||||
Operating Cash Flow | |||||
Capital Expenditure | |||||
Free Cash Flow |
Nov 2024 | Aug 2024 | May 2024 | Oct 2023 | Jul 2023 | Apr 2023 | Jan 2023 | Oct 2022 | Jul 2022 | Apr 2022 | Jan 2022 | Oct 2021 | Jul 2021 | May 2021 | Jan 2021 | Oct 2020 | Jul 2020 | May 2020 | Jan 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flows from Operating Activities | ||||||||||||||||||||
Net Income | ||||||||||||||||||||
Depreciation & Amortization | ||||||||||||||||||||
Deferred Income Taxes | ||||||||||||||||||||
Stock Based Compensation | ||||||||||||||||||||
Accounts Receivable | ||||||||||||||||||||
Inventory | ||||||||||||||||||||
Accounts Payable | ||||||||||||||||||||
Deferred Revenue | ||||||||||||||||||||
Other Non-Cash | ||||||||||||||||||||
Operating Cash Flow | ||||||||||||||||||||
Cash Flows from Investing Activities | ||||||||||||||||||||
PPE Investments | ||||||||||||||||||||
Net Acquisitions | ||||||||||||||||||||
Purchase of Investments | ||||||||||||||||||||
Sale of Investments | ||||||||||||||||||||
Other Investing Activity | ||||||||||||||||||||
Investing Cash Flow | ||||||||||||||||||||
Cash Flows from Financing Activities | ||||||||||||||||||||
Debt Issued | ||||||||||||||||||||
Proceeds from Debt Repayment | ||||||||||||||||||||
Debt Repayment | ||||||||||||||||||||
Proceeds from Sale of Equity | ||||||||||||||||||||
Equity Repurchased | ||||||||||||||||||||
Dividend Paid | ||||||||||||||||||||
Other Financing Activity | ||||||||||||||||||||
Financing Cash Flow | ||||||||||||||||||||
Cash Position | ||||||||||||||||||||
Beginning Cash Position | ||||||||||||||||||||
End Cash Position | ||||||||||||||||||||
Change in Cash | ||||||||||||||||||||
Free Cash Flow | ||||||||||||||||||||
Operating Cash Flow | ||||||||||||||||||||
Capital Expenditure | ||||||||||||||||||||
Free Cash Flow |